Novel ABCA1 peptide agonists with antidiabetic action

Previously, apoE-derived ABCA1 agonist peptides have been shown to possess anti-atherosclerotic and possibly antidiabetic properties. Here we assessed the in vitro and in vivo actions of a second generation of ABCA1 peptide agonists, CS6253 and T6991–2, on glucose homeostasis. The results show that...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cell Endocrinol
Main Authors: Azhar, Salman, Bittner, Stefanie, Hu, Jie, Shen, Wen-Jun, Cortez, Yuan, Hao, Xiao, Han, Lu, Lagerstedt, Jens O., Kraemer, Fredric B., Johansson, Jan O.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6626528/
https://ncbi.nlm.nih.gov/pubmed/30290217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2018.09.011
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares